Font size
Background and font color
Images
Text scoring
Regular version of the site
GPHC
Group of Pharmaceutical Companies
+7 (812) 779-30-27
+7 (812) 779-30-27 Multi-channel
Email
info@gphc.ru
The address
of. 335, 83/3, lit. A, BC Antares, Savushkina St., Saint Petersburg, 197374, Russian Federation

 
 
Working hours
Mon. – Fri .: from 9:00 to 18:00
Company
  • Company
  • History
  • Vacancy
  • Requisites
  • Documents
Catalog
  • Own products
  • Partner products
News
Documents
Contacts
en
ru
en
GPHC
Company
  • Company
  • History
  • Vacancy
  • Requisites
  • Documents
Catalog
  • Own products
    Own products
  • Partner products
    Partner products
News
Documents
Contacts
    +7 (812) 779-30-27
    +7 (812) 779-30-27 Multi-channel
    Email
    info@gphc.ru
    The address
    of. 335, 83/3, lit. A, BC Antares, Savushkina St., Saint Petersburg, 197374, Russian Federation

     
     
    Working hours
    Mon. – Fri .: from 9:00 to 18:00
    en
    ru
    en
    GPHC
    Company
    • Company
    • History
    • Vacancy
    • Requisites
    • Documents
    Catalog
    • Own products
      Own products
    • Partner products
      Partner products
    News
    Documents
    Contacts
      en
      ru
      +7 (812) 779-30-27 Multi-channel
      Email
      info@gphc.ru
      The address
      of. 335, 83/3, lit. A, BC Antares, Savushkina St., Saint Petersburg, 197374, Russian Federation

       
       
      Working hours
      Mon. – Fri .: from 9:00 to 18:00
      GPHC
      Telephones
      +7 (812) 779-30-27 Multi-channel
      Email
      info@gphc.ru
      The address
      of. 335, 83/3, lit. A, BC Antares, Savushkina St., Saint Petersburg, 197374, Russian Federation

       
       
      Working hours
      Mon. – Fri .: from 9:00 to 18:00
      GPHC
      • Company
        • Company
        • Company
        • History
        • Vacancy
        • Requisites
        • Documents
      • Catalog
        • Catalog
        • Own products
        • Partner products
      • News
      • Documents
      • Contacts
      • en
        • Language
        • en
        • ru
      • +7 (812) 779-30-27 Multi-channel
        • Telephones
        • +7 (812) 779-30-27 Multi-channel
      • of. 335, 83/3, lit. A, BC Antares, Savushkina St., Saint Petersburg, 197374, Russian Federation

         
         
      • info@gphc.ru
      • Mon. – Fri .: from 9:00 to 18:00
      Home
      —
      News
      —Sulbactam. New treatment options for critically ill patients.

      Sulbactam. New treatment options for critically ill patients.

      Sulbactam. New treatment options for critically ill patients.
      Common
      February 2024
      The GPHC company, along with well-known antibacterial drugs, was one of the first to bring to market a beta-lactamase inhibitor — SULBACTAM-GPHC® in the form of a single drug.

      The main effect of the drug SULBACTAM-GPHC® is to protect against the destruction of a number of beta-lactam antibiotics (for example, cephalosporins, penicillins) by enzymes - beta-lactamases. Beta-lactamases are substances synthesized by pathogenic bacteria that destroy antibiotics and make them inactive (ineffective), which causes the development of resistance to antibiotic therapy, including multiple ones. Multiple drug resistance leads to the development of extremely aggressive pathogens that cause nosocomial infections, which lead to severe consequences for both patients and the healthcare system as a whole.

      The advantage of SULBACTAM-GPHC® is the possibility of making a combination with an antibiotic within the wide permitted limits for the selection of effective personalized antibacterial therapy. Also, the use of LP SULBACTAM-GPHC® allows you to reduce the cost of therapy, in comparison with ready-made fixed combinations, which in turn leads to optimization of the costs of medical institutions.

      For more effective prevention and treatment of hospital infection and its complications, health experts in the round table format discuss new possibilities of antibacterial therapy for patients in critical conditions, taking into account new possibilities of combining antibiotics with a beta-lactamase inhibitor.

      The structure of the round table:

      — "Sulbactam and other "classic" beta lactamase inhibitors: "basic" information"

      Speaker: Andrey V. Dehnich — Candidate of Medical Sciences, Deputy Director for Scientific Work of the Research Institute of Antimicrobial Chemotherapy of the Smolensk State Medical University of the Ministry of Health of the Russian Federation (Russia, Smolensk);

      — "Sulbaktam. Clinical application experience and practical advice"

      Speaker: Konstantin Nikolaevich Zolotukhin — Candidate of Medical Sciences, Chief Freelance Anesthesiologist-Resuscitator of the Ministry of Health of the Republic of Bashkortostan, Head of the Department of Anesthesiology and Intensive Care No. 1 of the G.G. Kuvatov RCB (Russia, Ufa);

      — "Sulbaktam. Where does an intensive care doctor need him?"

      Speaker: Vladimir V. Kulabukhov - President of the Russian Sepsis Forum, leading researcher at the State Medical Institution "N.V. Sklifosovsky Research Institute of Emergency Medicine of the Moscow City Department of Health" (Russia, Moscow);

      —  Answers to questions from the participants.

      The video of the round table is available at the link: https://www.youtube.com/watch?v=IT-8qLgQPwo

      Back to the list
      Company
      Catalog
      Documents
      Contacts
      en
      ru
      en
      +7 (812) 779-30-27
      +7 (812) 779-30-27 Multi-channel
      Email
      info@gphc.ru
      The address
      of. 335, 83/3, lit. A, BC Antares, Savushkina St., Saint Petersburg, 197374, Russian Federation

       
       
      Working hours
      Mon. – Fri .: from 9:00 to 18:00
      info@gphc.ru
      of. 335, 83/3, lit. A, BC Antares, Savushkina St., Saint Petersburg, 197374, Russian Federation

       
       
      © 2023-2025, GPHC LLC.
      Privacy Policy
      Site map
      Homepage Company Catalog Contacts Documents Requisites News Career